Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 9—September 2017

Epidemiology of Salmonella enterica Serotype Dublin Infections among Humans, United States, 1968–2013

R. Reid Harvey1, Cindy R. Friedman, Stacy M. Crim, Michael Judd, Kelly A. Barrett, Beth Tolar, Jason P. Folster, Patricia M. Griffin, and Allison C. BrownComments to Author 
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Table 2

Antimicrobial drug resistance in Salmonella enterica serotype Dublin and other Salmonella, United States, 1996–2013*

Resistance pattern Salmonella Dublin, no. (%), n = 102 Other Salmonella, no. (%), n = 33,415
Pansusceptible 42 (41) 26,552 (79)
Resistant to >1 class 60 (59) 6,863 (21)
Resistant to >3 classes 56 (55) 4,013 (12)
Resistant to >5 classes 47 (46) 2,374 (7)
Resistant to >7 classes 32 (31) 601 (2)
Resistant to at least ACSSuT† 42 (41) 2,156 (6)
Resistant to at least ACSSuTAuCx‡ 29 (28) 581 (2)
Resistant to ceftriaxone 32 (31) 947 (3)
Resistant to nalidixic acid 6 (6) 643 (2)
Resistant to nalidixic acid and ceftriaxone 4 (4) 39 (0.1)

*Data from the National Antimicrobial Resistance Monitoring System. p<0.01 for all.
†Resistant to ampicillin, chloramphenicol, streptomycin, sulfamethoxazole/sulfisoxazole,and tetracycline.
‡Resistant to ACSSuT, amoxicillin–clavulanic acid, and ceftriaxone.

Main Article

1Current affiliation: Centers for Disease Control and Prevention, Morgantown, WV, USA.

Page created: August 15, 2017
Page updated: August 15, 2017
Page reviewed: August 15, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.